The acquisition strengthens the cold sterilisation specialist’s position in the market and expands its geographic position in southern France.
Both companies are based in France.
Chinese biotechnology company China Regenerative Medicine International Ltd plans to acquire a 20% share in Denmark-based image analysis software developer RetinaLyze A/S.
M3 Inc plans to acquire Cosmotec Co Ltd for CNY1.06bn ($9.03m).
Both the entities involved in the acquisition are based in Japan.